Distribution of Maternal High-Risk Factors Across Amniotic Fluid Volume Categories in High-Risk Pregnancies

Main Article Content

Kanwal Bano
Dr Maaz Khan
Attiqa Raqeeb
Aneeza Eman
Aimen Saeed
Mehwish Kalsoom

Abstract

Background: Amniotic fluid volume abnormalities are common in high-risk pregnancies and reflect underlying maternal and fetal conditions, yet the distribution of specific maternal risk factors across different amniotic fluid categories remains insufficiently characterized. Objective: To evaluate the frequency and distribution of maternal high-risk factors across normal amniotic fluid volume, oligohydramnios, and polyhydramnios in high-risk pregnancies. Methods: This cross-sectional observational study included 81 high-risk pregnant women at ≥28 weeks gestation. Amniotic fluid volume was assessed using the amniotic fluid index and categorized as normal (5–25 cm), oligohydramnios (<5 cm), or polyhydramnios (>25 cm). Maternal risk factors, including hypertension, diabetes mellitus, preeclampsia, obstetric history, intrauterine growth restriction, and congenital anomalies, were recorded. Associations were analyzed using chi-square tests and odds ratios with 95% confidence intervals. Results: Normal amniotic fluid volume was observed in 60.5% of cases, oligohydramnios in 19.8%, and polyhydramnios in 19.8%. Intrauterine growth restriction was significantly associated with oligohydramnios (31.2% vs 8.2%; OR 5.13, p=0.02), while diabetes mellitus was strongly associated with polyhydramnios (37.5% vs 10.2%; OR 5.28, p=0.02). Hypertension and preeclampsia showed higher prevalence in oligohydramnios but were not statistically significant. The presence of ≥2 risk factors was associated with a threefold increase in abnormal amniotic fluid volume (OR 3.24, p=0.03). Conclusion: Maternal high-risk factors exhibit distinct distribution patterns across amniotic fluid categories, with oligohydramnios linked to placental insufficiency-related conditions and polyhydramnios associated with metabolic and structural factors. These patterns support targeted clinical evaluation and improved risk stratification.

Article Details

Section

Articles

How to Cite

[1]
Kanwal Bano et al. 2026. Distribution of Maternal High-Risk Factors Across Amniotic Fluid Volume Categories in High-Risk Pregnancies. Journal of Health, Wellness and Community Research. 4, 3 (Feb. 2026), 1–9. DOI:https://doi.org/10.61919/52e0a373.

References

1. Alscreen M, et al. Amniotic fluid physiology. Obstet Gynecol Clin North Am. 2019;46(2):227–240.

2. Crellin HB, Singh V. Sonography evaluation of amniotic fluid. StatPearls. 2025.

3. Yeung YK, et al. Longitudinal fetal growth parameters. Ultrasound Obstet Gynecol. 2025;66(3):314–323.

4. ACOG Committee Opinion. Indications for outpatient antenatal fetal surveillance. Obstet Gynecol. 2021;137(6):e177–197.

5. Mandal A, et al. IUGR and perinatal outcome in oligohydramnios. Asian J Med Sci. 2022;13(8):186–194.

6. Hassan T ul, et al. Association of preeclampsia with oligohydramnios. J Mod Health Rehabil Sci. 2024;1:1–5.

7. Horcas-Martín M, et al. Polyhydramnios at term in gestational diabetes. Children. 2025;12(7).

8. Bakhsh H, et al. Amniotic fluid disorders and prenatal outcome. BMC Pregnancy Childbirth. 2021;21(1).

9. Akthar S, et al. Impact of low AFI at term on perinatal outcome. Int J Clin Obstet Gynaecol. 2024;110(3):110–114.

10. Liu Y, et al. Prenatal diagnosis of chromosomal aberrations in polyhydramnios. J Matern Fetal Neonatal Med. 2024;37(1):2344089.

11. Jha P, et al. Assessment of amniotic fluid volume in pregnancy. Radiographics. 2023;43(6).

12. Sgayer I, et al. Borderline amniotic fluid levels and adverse outcome. Ultrasound Obstet Gynecol. 2025;66(5):562–570.

13. Blitz MJ, et al. Maternal BMI and amniotic fluid index. J Ultrasound Med. 2018;37(3):561–568.

14. Dammer U, et al. Perinatal outcome with isolated oligohydramnios. In Vivo. 2024;38(2):754.

15. Molla M, et al. Adverse perinatal outcomes with oligohydramnios. Front Glob Womens Health. 2022;3:958617.

16. Fatema J, et al. Oligohydramnios and maternal/neonatal outcomes.

17. Kechagias KS, et al. Outcomes in idiopathic polyhydramnios. Sci Rep. 2024;14(1):5296.

18. Pagan M, et al. Idiopathic polyhydramnios and pregnancy outcome. Ultrasound Obstet Gynecol. 2023;61(3):302–309.

19. Weerakkody Y, Knipe H. Hydrops fetalis. Radiopaedia.org. 2010.

20. Gao H, et al. Pregnancy outcomes in idiopathic oligohydramnios. Int J Womens Health. 2025;17:1665–1672.

21. Whittington JR, et al. Amniotic fluid and postnatal outcomes. Int J Womens Health. 2023;15:117–124.

22. Yamaji N, et al. Tocolytic therapy in high-risk populations. Children. 2023;10(3):443.